First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
Key populations brief
Accessed 2017
Global Plan to end TB 2016-2020
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
Accessed November 2, 2017
National Tuberculosis and Leprosy Conrol Programme
Accessed November 2, 2017
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
Overcoming HIV-related stigma and discrimination in health- care settings and beyond
UNAIDS 2017 | REFERENCE